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o Depression or
ntidepressants Increase
ardiovascular Mortality?
he Absence of Proof Might Be More
mportant Than the Proof of Absence*
anjiv M. Narayan, MD,
urray B. Stein, MD, MPH
an Diego, California
ajor depressive disorder and coronary heart disease
CHD) are 2 of the most important public health problems
n the U.S. Depression affects 13 to 14 million U.S. adults
er year (1), many of whom have comorbid physical
onditions (2). Coronary disease causes over 800,000
eaths/year (3) and is the leading identified pathology (4)
or the 300,000 annual cases of sudden cardiac arrest (SCA)
n the U.S. (5). Identifying a biological link between
epression and coronary disease would therefore have tre-
endous public health implications, yet remains highly
ontroversial (6). A major challenge is to separate whether
epression is related causally to future coronary disease, or
elated by reverse causality in which individuals with coro-
ary disease are more likely to develop depression (7).
See page 950
Observational studies suggest that major depressive dis-
rder does indeed increase the incidence of events due to
HD. Two recent meta-analyses of retrospective studies
eported that depression predicted future fatal CHD or
yocardial infarction (MI) with a hazard ratio (HR) of 1.81
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
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harmaceuticals, Inc., and Virtual Reality Medical Center.95% confidence interval [CI]: 1.53 to 2.15) over 10.8 years
n 124,509 individuals (7), and with an HR of 1.64 (95%
I: 1.29 to 2.08) in 36,549 individuals (8). However, these
eemingly robust associations must be taken in context.
irst, depressed patients often exhibit traditional coro-
ary risk factors. Indeed, the HRs in these meta-analyses
ere substantially attenuated when adjusted by cardiac
omorbidities (7,8). Second, meta-analyses adjust only for
eported risk factors, yet many of the index studies failed to
ecord serum lipids, body mass index, the metabolic syn-
rome, or physical inactivity, all of which might contribute
o CHD events. Third, the index studies were statistically
eterogeneous (7,8) in their definitions of depression, their
nclusion of prior CHD (with the concomitant risk of
everse causality), in their duration of follow-up and mea-
ured end points, and as is often the case, in under-
epresenting negative studies.
It is in this context that the work by Whang et al. (9) in
his issue of the Journal is particularly exciting. The authors
rospectively studied 63,469 women in the Nurses Health
tudy without baseline coronary disease, stroke, or malig-
ancy for cardiovascular events on follow-up between 1992
nd 2004. The authors found that major depression, defined
y a validated 5-point mental health index score (MHI-5)
53 and antidepressant use (in recent cohorts), predicted a
ombined end point of nonfatal MI, SCA, and fatal CHD
vents on multivariate analysis. Intriguingly, HRs were
tronger for fatal than for nonfatal events and were actually
riven by the association with SCA. On stepwise regression
nalysis, MHI 53 or antidepressant use provided an HR
or SCA of 2.33 (95% CI: 1.47 to 3.70, p  0.001).
otably, proportional hazards models showed that antide-
ressant use alone provided a higher HR for SCA of 3.34
95% CI: 2.03 to 5.50), but was unrelated to fatal CHD or
onfatal MI.
The authors should be congratulated for these important
ata on the potential etiologic role of depression and its
reatment on cardiovascular outcomes in a very large cohort
f healthy individuals. A prospective design with question-
aires administered every 2 years and excellent end point
djudication also allowed the group to demonstrate that
epression was predominantly associated with SCA and to
rovocatively implicate antidepressant drug use in the
echanism for this observation.
These results raise some important questions. The first
elates to the accuracy of self-reporting of clinical informa-
ion from questionnaires. A recent meta-analysis reported
hat when depression was identified from scores, it was less
trongly associated with CHD than when diagnosed by
xperts (7). This might contribute to the relatively weak
djusted HRs of an MHI score53 for adverse events (95%
I: 1.13 to 1.49) (Table 2 of Whang et al. [9]) and higher
Rs when antidepressant use was added to an MHI score
53 (95% CI: 1.2 to 2.33) (Table 4 of Whang et al. [9]).
ecause clinical diagnosis is the gold standard for identify-
i
t
n
c
n
“
r
(
s
d
s
t
u
w
i
d
s
p
p
s
w
a
t
n
a
b
t
t
d
w
p
(
p
o
t
t
d
c
n
a
c
m
d
f
v
d
C
c
h
t
w
s
a
e
d
a
(
b
w
m
o
v
e
W
v
s
t
d
a
w
o
r
(
t
t
W
n
f
a
a
s
S
a
p
w
s
f
m
m
d
l
(
(
h
d
i
s
t
i
r
S
t
s
960 Narayan and Stein JACC Vol. 53, No. 11, 2009
Antidepressants and Cardiovascular Mortality March 17, 2009:959–61ng major depression, some nurses with MHI 53 might
herefore have had mild depression or have been misdiag-
osed. Self-reporting of nonfatal MI and other cardiac
omorbidities is also problematic, because events that were
ot corroborated by clinical records were still included as
probable.” Because depressed subjects are more likely to
eport ailments and physical symptoms such as chest pain
10), this might contribute to an alpha error (falsely
trengthening the association between depression and car-
iac events), although the authors state that results were
imilar when such cases were excluded. Conversely, al-
hough unreported events could not be uncovered, it is
nlikely that this population of relatively young nurses
ould fail to report MI.
Second, multivariate analyses might not fully adjust for
mportant comorbidities. Whang et al. (9) performed a
etailed analysis of clinical features omitted from many prior
tudies (7,8), including serum lipids, body mass index, and
hysical activity. The results confirm those from smaller
rior studies, that depressed individuals were more likely to
elf-report hypertension, diabetes, and high cholesterol and
ere more likely to be smokers, obese, and less physically
ctive. Depressed women were also younger and more likely
o use regular aspirin and multivitamins, yet less likely to use
-3 fatty acids. However, the use of beta-blockers and other
gents linked with depression was not reported. Moreover,
aseline electrocardiogram abnormalities, ventricular hyper-
rophy, or structural heart disease were not reported despite
heir strong associations with CHD and SCA (11).
In addition, psychiatric confounders such as anxiety
isorders are highly comorbid with depressive disorders yet
ere not considered in the analyses. For instance, a recent
rospective study from the Women’s Health Initiative
WHI) observational study found an association between
anic attacks and incident cardiovascular events (12). An-
ther recent prospective study (led by 1 of the coauthors of
he present report) from the Normative Aging Study found
hat 1 specific anxiety disorder, post-traumatic stress disor-
er (PTSD), was associated with incident CHD even after
ontrolling for depressive symptoms (13). These factors do
ot invalidate these results but rather suggest that a wider
rray of neuropsychiatric disorders might affect cardiovas-
ular outcomes.
Third, reverse causality must be considered. A recent
eta-analysis suggested reverse causality between coronary
isease and depression in 17,842 patients with an HR of 1.8
or adverse outcome (7). Whang et al. (9) used a time-
arying analysis of interim nonfatal MI to show that the
uration of time since nonfatal MI did not impact future
HD events. The authors use these data to exclude reverse
ausality, although they did not analyze whether subjects
ad angina, heart failure, or other cardiac diseases other
han nonfatal MI. In addition, the study examined only
omen, and future work should also examine men.
This leads us to examine the final conclusion of thistudy, that the use of antidepressant medications was tssociated with an elevated risk of SCA, and that this
xplained most of the CHD events associated with major
epression. The relationship between antidepressant use
nd SCA remained after adjusting for clinical confounders
Table 4 in Whang et al. [9]), whereas the relationship
etween antidepressant use and nonfatal MI or fatal CHD
as less clear.
This surprising result merits scrutiny. Numerous phar-
aceutical agents might contribute to arrhythmic mortality,
ften by blocking repolarizing currents that exaggerate
entricular repolarization dispersion and may prolong the
lectrocardiographic QT interval (14). The report by
hang et al. (9) agrees with a recent study of 2,228 SCA
ictims and 4,164 age- and sex-matched control subjects
howing that depression was more prevalent in SCA victims
han control subjects (15). Depression in that study was also
efined by antidepressant use as well as clinical history,
lthough the predictive value of antidepressant use alone
as not analyzed (15). In the study byWhang et al. (9), 61%
f subjects using antidepressants used selective serotonin
euptake inhibitors (SSRIs), whereas 39% used “other”
nonspecified) agents. The authors stated no difference in
he results for SSRI or non-SSRI agents, although CIs for
he association with non-SSRI agents crossed unity.
It is unclear whether SSRI agents might cause SCA.
hile cardiac events are well documented with the use of
on-SSRIs such as tricyclic antidepressants (16), evidence
or a link with SSRIs is mixed (17). On one hand, SSRI
gents have been linked with ventricular arrhythmias (18)
nd increased mortality (19) in small clinical and animal
tudies. On the other hand, recent studies suggest that
SRIs might prevent future CHD events and MI (20,21),
nd 1 trial (22) reported that the SSRI sertraline did not
rolong QT or elevate morbidity or mortality in patients
ith acute coronary syndrome, albeit with relatively pre-
erved left ventricular ejection fraction (52%) on short
ollow-up (24 weeks).
Moreover, it is quite possible that antidepressant use
erely indicates that depression is of sufficient severity to
erit treatment. It is well established that patients with
epression after acute coronary syndrome, for example, are
ess likely to adhere to their cardiac medication regimens
23), although treating the depression improves adherence
24). In addition, a recent prospective study of patients with
eart failure, albeit in a smaller population, reported that
epression but not antidepressant use was associated with
ncreased mortality (25). Additional studies are clearly neces-
ary to resolve this controversy.
In conclusion, Whang et al. (9) present exciting results
hat major depressive disorder was associated with an
ncreased risk of nonfatal MI, SCA, and fatal CHD in
elatively healthy women with no prior coronary disease.
urprisingly, adverse outcomes consisted mostly of SCA
hat, in turn, was most strongly associated with antidepres-
ant use. Clearly, the burden of proof rests on confirming
his association. The authors conclude that, at the present
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March 17, 2009:959–61 Antidepressants and Cardiovascular Mortalityime, the benefits of appropriately prescribed antidepres-
ants likely outweigh the risk of SCA. We agree. There are
bundant data attesting to the safety and efficacy of SSRIs in
articular, and a relative paucity of data showing adverse
ardiac effects. Moreover, if antidepressant use merely indi-
ates severe depression, these results could suggest that
epression should actually be treated more aggressively.
hus, at the present time, the absence of proof that
ntidepressants might cause cardiac events is more relevant
han conclusive proof that this effect is absent. Nevertheless,
hese findings are sufficiently sobering to warrant height-
ned clinical surveillance and to initiate studies to defini-
ively address this relationship.
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